Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome

Alimentary Pharmacology and Therapeutics

Volumn 44, Issue 5, 2016, Pages 447-459

  Peters, S L ^a   Yao, C K ^a   Philpott, H ^a   Yelland, G W ^a   Muir, J G ^a   Gibson, P R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DISACCHARIDE; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYOL;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIET THERAPY; FEMALE; GASTROINTESTINAL SYMPTOM; GUT DIRECTED HYPNOTHERAPY; HUMAN; HYPNOSIS; HYPNOTHERAPY; INTERMETHOD COMPARISON; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VISUAL ANALOG SCALE;

EID: 84982786765     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13706     Document Type: Article

References (33)

1. Hillilä M, Färkkilä M. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharm Ther 2004; 20: 339–45.
2. Shepherd S, Parker F, Muir J, Gibson P. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008; 6: 765–71.
3. Ong D, Mitchell S, Barrett J, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010; 25: 1366–73.
4. Barrett J, Gearry R, Muir J, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 2010; 31: 874–82.
5. Marciani L, Cox E, Hoad C, et al. Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology 2010; 138: 469–77.
6. Staudacher HM, Lomer MC, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012; 142: 1510–8.
7. Staudacher H, Whelan K, Irving P, Lomer M. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011; 24: 487–95.
8. De Roest R, Dobbs B, Chapman B, et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract 2013; 67: 895–903.
9. Biesiekierski J, Peters S, Newnham E, Rosella O, Muir J, Gibson P. No effects of gluten in patients with self-reported non-celiac gluten sensitivity following dietary reduction of low-fermentable, poorly-absorbed, short-chain carbohydrates. Gastroenterology 2013; 145: 320–8.
10. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006; 106: 1631–9.
11. Halmos E, Power V, Shepherd S, Gibson P, Muir J. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146: 67–75.
12. Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr 2016; 55: 897–906.
13. Peters S, Muir J, Gibson P. Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther 2015; 41: 1104–15.
14. Whorwell P, Prior A, Faragher E. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984; 324: 1232–4.
15. Palsson OS, Turner MJ, Whitehead WE. Hypnosis home treatment for irritable bowel syndrome: a pilot study. Int J Clin Exp Hyp 2006; 54: 85–99.
16. Roberts L, Wilson S, Singh S, Roalfe A, Greenfield S. Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial. Brit J Gen Pract 2006; 56: 115–21.
17. Lindfors P, Unge P, Arvidsson P, et al. Effects of gut-directed hypnotherapy on IBS in different clinical settings – results from two randomized, controlled trials. Am J Gastroenterol 2011; 107: 276–85.
18. Moser G, Trägner S, Gajowniczek EE, et al. Long-term success of gut-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2013; 108: 602–9.
19. Boot WR, Simons DJ, Stothart C, Stutts C. The pervasive problem with placebos in psychology why active control groups are not sufficient to rule out placebo effects. Perspect Psychol Sci 2013; 8: 445–54.
20. Francis C, Morris J, Whorwell P. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395–402.
21. Spielberger C. State-Trait Personality Inventory (STPI) Research Manual Sampler Set. Mind Garden Inc: CA USA, 1995.
22. Snaith R, Zigmond A. The Hospital Anxiety and Depression Scale Manual. Windsor, Berkshire: Nfer-Nelson, 1994.
23. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res 1997; 42: 17–41.
24. Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000; 95: 999–1007.
25. Miller V, Carruthers HR, Morris J, Hasan SS, Archbold S, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther 2015; 41: 844–55.
26. Chumpitazi B, Cope J, Hollister E, et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharm Ther 2015; 42: 418–27.
27. McIntosh K, Reed DE, Schneider T, et al. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut 2016; doi: 10.1136/gutjnl-2015-311339 [Epub ahead of print].
28. Anonymous. Does a low FODMAP diet help IBS? Drug Ther Bull 2015; 53: 93–6.
29. Ledochowski M, Sperner-Unterweger B, Widner B, Fuchs D. Fructose malabsorption is associated with early signs of mental depression. Eur J Med Res 1998; 3: 295–8.
30. Ledochowski M, Widner B, Bair H, Probst T, Fuchs D. Fructose-and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol 2000; 35: 1048–52.
31. Simpson H, Campbell B. Review article: dietary fibre–microbiota interactions. Aliment Pharmacol Ther 2015; 42: 158–79.
32. Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015; 64: 93–100.
33. Koven NS, Abry AW. The clinical basis of orthorexia nervosa: emerging perspectives. Neuropsychiatr Dis Treat 2015; 11: 385.